Advertisement

Endoscopic Resection of Early Gastric Cardiac Cancer

  • Guifang Xu
  • Rui Li
  • Dongtao Shi
  • Qin Huang
  • Hiroshi Mashimo
Chapter

Abstract

For early gastric cardiac carcinoma at the pT1 stage, endoscopic resection, especially endoscopic submucosal dissection, is a preferred procedure for cases with no or minimal risk of nodal metastasis. Careful preparation and execution of endoscopic therapy may secure a successful resection. Post-resection complications such as perforation, delayed bleeding, and stenosis should be treated immediately and appropriately. All patients need to be placed on endoscopic surveillance for monitoring tumor recurrence and complications.

Keywords

Early gastric carcinoma Gastric cardia Stomach Cancer Endoscopic submucosal dissection 

References

  1. 1.
    Gotoda T, Yanagisawa A, Sasako M, et al. Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer. 2000;3:219–25.PubMedCrossRefPubMedCentralGoogle Scholar
  2. 2.
    Ono H, Yao K, Fujishiro M, et al. Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer. Dig Endosc. 2016;28(1):3–15.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Chinese Society of Digestive Endoscopy Consensus for early gastric carcinoma diagnosis and treatment in China. Chin J Dig Endosc. 2014;31:361–377.Google Scholar
  4. 4.
    Ahmad R, Setia N, Schmidt BH, et al. Predictors of lymph node metastasis in Western Early Gastric Cancer. J Gastroint Surg. 2016;20:531–8.CrossRefGoogle Scholar
  5. 5.
    Barreto SG, Windsor JA. Redefining early gastric cancer. Surg Endosc. 2016;30:24–37.PubMedCrossRefPubMedCentralGoogle Scholar
  6. 6.
    Jin EH, Lee DH, Jung SA, et al. Clinicopathologic factors and molecular markers related to lymph node metastasis in early gastric cancer. World J Gastroenterol. 2015;21:571–7.PubMedPubMedCentralCrossRefGoogle Scholar
  7. 7.
    Kang HJ, Kim DH, Jeon TY, et al. Lymph node metastasis from intestinal-type early gastric cancer: experience in a single institution and reassessment of the extended criteria for endoscopic submucosal dissection. Gastrointest Endosc. 2010;72:508–55.PubMedCrossRefPubMedCentralGoogle Scholar
  8. 8.
    Huang Q, Fang C, Shi J, et al. Differences in clinicopathology of early gastric carcinoma between proximal and distal location in 438 Chinese patients. Scientific Report. 2015;5:13439.CrossRefGoogle Scholar
  9. 9.
    Fang C, Shi J, Sun Q, et al. Risk factors of lymph node metastasis in early gastric carcinomas diagnosed with WHO criteria in 379 Chinese patients. J Dig Dis. 2016;17(8):526–37.CrossRefPubMedGoogle Scholar
  10. 10.
    Guo TJ, Qin JY, Zhu LL, et al. Feasible endoscopic therapy for early gastric cancer. World J Gastroenterol. 2015;21:13325–31.PubMedPubMedCentralCrossRefGoogle Scholar
  11. 11.
    Yang HJ, Kim SG, Lim JH, et al. Predictors of lymph node metastasis in patients with non-curative endoscopic resection of early gastric cancer. Surg Endosc. 2014.  https://doi.org/10.1007/s00464-014-3780-7.
  12. 12.
    Zhao BW, Chen YM, Jiang SS, et al. Lymph node metastasis, a unique independent prognostic factor in early gastric cancer. PLoS One. 2015;10:e0129531.PubMedPubMedCentralCrossRefGoogle Scholar
  13. 13.
    Park JH, Lee SH, Park JM, et al. Prediction of the indication criteria for endoscopic resection of early gastric cancer. World J Gastroenterol. 2015;21:11160–7.PubMedPubMedCentralCrossRefGoogle Scholar
  14. 14.
    Zhao X, Cai A, Xi H, et al. Predictive factors for lymph node metastasis in undifferentiated early gastric cancer: a systematic review and meta-analysis. J Gastrointest Surg. 2017.  https://doi.org/10.1007/s11605-017-3364-7. [Epub ahead of print].
  15. 15.
    Sano T, Coit DG, Kim HH, et al. Proposal of a new stage grouping of gastric cancer for TNM classification: International Gastric Cancer Association staging project. Gastric Cancer. 2017;20(2):217–25.PubMedPubMedCentralCrossRefGoogle Scholar
  16. 16.
    Yu HP, Fang C, Chen L, et al. Worse prognosis in papillary, compared to tubular, early gastric carcinoma. J Cancer. 2017;8(1):117–23.PubMedPubMedCentralCrossRefGoogle Scholar
  17. 17.
    Yasuda K, Adachi Y, Shiraishi N, Maeo S, Kitano S. Papillary adenocarcinoma of the stomach. Gastric Cancer. 2000;3:33–8.CrossRefPubMedGoogle Scholar
  18. 18.
    Lee HJ, Kim GH, Park do Y, et al. Is endoscopic submucosal dissection safe for papillary adenocarcinoma of the stomach? World J Gastroenterol. 2015;21:3944–52.PubMedPubMedCentralCrossRefGoogle Scholar
  19. 19.
    Sekiguchi M, Kushima R, Oda I, et al. Clinical significance of a papillary adenocarcinoma component in early gastric cancer: a single-center retrospective analysis of 628 surgically resected early gastric cancers. J Gastroenterol. 2015;50(4):424–34.PubMedCrossRefPubMedCentralGoogle Scholar
  20. 20.
    Koseki K, Takizawa T, Koike M, et al. Distinction of differentiated type early gastric carcinoma with gastric type mucin expression. Cancer. 2000;89:724–32.PubMedCrossRefPubMedCentralGoogle Scholar
  21. 21.
    Lee SH, Jee SR, Kim JH, Seol SY. Intramucosal gastric cancer: the rate of lymph node metastasis in signet ring cell carcinoma is as low as that in well-differentiated adenocarcinoma. Eur J Gastroenterol Hepatol. 2015;27:170–4.PubMedCrossRefPubMedCentralGoogle Scholar
  22. 22.
    Chiu CT, Kuo CJ, Yeh TS, et al. Early signet ring cell gastric cancer. Dig Dis Sci. 2011;56:1749–56.PubMedCrossRefPubMedCentralGoogle Scholar
  23. 23.
    Gronnier C, Messager M, Robb WB, et al. Is the negative prognostic impact of signet ring cell histology maintained in early gastric adenocarcinoma? Surgery. 2013;154:1093–9.PubMedCrossRefPubMedCentralGoogle Scholar
  24. 24.
    Hyung WJ, Noh SH, Lee JH, et al. Early gastric carcinoma with signet ring cell histology. Cancer. 2002;94:78–83.PubMedCrossRefPubMedCentralGoogle Scholar
  25. 25.
    Guo CG, Zhao DB, Liu Q, et al. Risk factors for lymph node metastasis in early gastric cancer with signet ring cell carcinoma. J Gastroint Surg. 2015;19:1958–65.CrossRefGoogle Scholar
  26. 26.
    Pyo JH, Shin CM, Lee H, et al. A risk-prediction model based on lymph-node metastasis for incorporation into a treatment algorithm for signet ring cell-type intramucosal gastric cancer. Ann Surg. 2016;264(6):1038–43.PubMedCrossRefPubMedCentralGoogle Scholar
  27. 27.
    Kim YH, Kim JH, Kim H, et al. Is the recent WHO histological classification for gastric cancer helpful for application to endoscopic resection? Gastric Cancer. 2016;19:869–75.PubMedCrossRefPubMedCentralGoogle Scholar
  28. 28.
    Fujita H, Lennerz JK, Chung DC, et al. Endoscopic surveillance of patients with hereditary diffuse gastric cancer: biopsy recommendations after topographic distribution of cancer foci in a series of 10 CDH1-mutated gastrectomies. Am J Surg Pathol. 2012;36:1709–17.PubMedCrossRefPubMedCentralGoogle Scholar
  29. 29.
    Ha TK, An JY, Youn HK, Noh JH, Sohn TS, Kim S. Indication for endoscopic mucosal resection in early signet ring cell gastric cancer. Ann Surg Oncol. 2008;15:508–13.PubMedCrossRefPubMedCentralGoogle Scholar
  30. 30.
    Tong JH, Sun Z, Wang ZN, et al. Early gastric cancer with signet-ring cell histologic type: risk factors of lymph node metastasis and indications of endoscopic surgery. Surgery. 2011;149:356–63.PubMedCrossRefGoogle Scholar
  31. 31.
    Kim HM, Pak KH, Chung MJ, et al. Early gastric cancer of signet ring cell carcinoma is more amenable to endoscopic treatment than is early gastric cancer of poorly differentiated tubular adenocarcinoma in select tumor conditions. Surg Endosc. 2011;25:3087–93.PubMedCrossRefPubMedCentralGoogle Scholar
  32. 32.
    Matsuda T, Takeuchi H, Tsuwano S, Nakahara T, Mukai M, Kitagawa Y. Sentinel node mapping in adenocarcinoma of the esophagogastric junction. World J Surg. 2014;38(9):2337–44.PubMedPubMedCentralCrossRefGoogle Scholar
  33. 33.
    Fukase K, Kawata S. Evaluation of the efficacy of endoscopic treatment for early gastric cancer considered in terms of long-term prognosis more than 10 years: a comparison with surgical treatment. Fertil Steril. 2004;82(3):241–7.Google Scholar
  34. 34.
    Choi KS, Jung HY, Choi KD, et al. EMR versus gastrectomy for intramucosal gastric cancer: comparison of long-term outcomes. Gastrointest Endosc. 2011;73(5):942–8.PubMedPubMedCentralCrossRefGoogle Scholar
  35. 35.
    Chiu PW, Teoh AY, To K F, et al. Endoscopic submucosal dissection (ESD) compared with gastrectomy for treatment of early gastric neoplasia: a retrospective cohort study. Surg Endosc. 2012;26(12):3584–91.PubMedCrossRefPubMedCentralGoogle Scholar
  36. 36.
    Tada M, Shimada M, Murakami F. Development of the strip-off biopsy. Gastroenterol Endosc. 1984;26(6):833–9.Google Scholar
  37. 37.
    Takekoshi T, Baba Y, Ota H, et al. Endoscopic resection of early gastric carcinoma: results of a retrospective analysis of 308 cases. Endoscopy. 1994;26(4):352–8.PubMedCrossRefGoogle Scholar
  38. 38.
    Gotoda T, Kondo H, Ono H, et al. A new endoscopic mucosal resection procedure using an insulation-tipped electrosurgical knife for rectal flat lesions: report of two cases. Gastrointest Endosc. 1999;50(4):560–3.PubMedCrossRefGoogle Scholar
  39. 39.
    Lian J, Chen S, Zhang Y, et al. A meta-analysis of endoscopic submucosal dissection and EMR for early gastric cancer. Gastrointest Endosc. 2012;76(4):763–70.PubMedCrossRefGoogle Scholar
  40. 40.
    Yamamoto H, Kita H. Endoscopic therapy of early gastric cancer. Best Pract Res Clin Gastroenterol. 2006;19(6):909–26.CrossRefGoogle Scholar
  41. 41.
    Chaves DM, Sakai P, Mester M, et al. A new endoscopic technique for the resection of flat polypoid lesions. Gastrointest Endosc. 1994;40(2):224–6.PubMedCrossRefPubMedCentralGoogle Scholar
  42. 42.
    Horiki N, Omata F, Uemura M, et al. Risk for local recurrence of early gastric cancer treated with piecemeal endoscopic mucosal resection during a 10-year follow-up period. Surg Endosc. 2012;26(1):72–8.PubMedCrossRefPubMedCentralGoogle Scholar
  43. 43.
    Kojima T, Parra-Blanco A, Takahashi H, et al. Outcome of endoscopic mucosal resection for early gastric cancer: review of the Japanese literature. Gastrointest Endosc. 1998;48(5):550.PubMedCrossRefPubMedCentralGoogle Scholar
  44. 44.
    Kim JJ, Lee JH, Jung HY, et al. EMR for early gastric cancer in Korea: a multicenter retrospective study. Gastrointest Endosc. 2007;66(4):693.PubMedCrossRefPubMedCentralGoogle Scholar
  45. 45.
    Oda I, Saito D, Tada M, et al. A multicenter retrospective study of endoscopic resection for early gastric cancer. Gastric Cancer. 2006;9(4):262.PubMedCrossRefPubMedCentralGoogle Scholar
  46. 46.
    Endoscopic treatment of early cardia cancer, pull the screen for esophageal cancer, head and neck cancer associated with esophageal cancer, Beijing Union Medical College, 刘勇. 内镜治疗早期贲门癌、拉网筛查食管癌、头颈部癌合并食管癌的相关研究[D]. 北京协和医学院, 2016 (in Chinese).Google Scholar
  47. 47.
    Lv Y, Zhang XQ, Zou XP, et al. Comparison of endoscopic submucosal dissection and endoscopic mucosal resection in the treatment of precancerous lesions and early cancer of the gastroesophageal junction. J Dig Endosc. 2012;29(5):243–6. (in Chinese).Google Scholar
  48. 48.
    Shimizu Y, Takahashi M, Yoshida T, et al. Endoscopic resection (endoscopic mucosal resection/endoscopic submucosal dissection) for superficial esophageal squamous cell carcinoma: current status of various techniques. Dig Endosc. 2013;25(Suppl 1):13–9.PubMedCrossRefPubMedCentralGoogle Scholar
  49. 49.
    Choi MK, Kim GH, Park do Y, et al. Long-term outcomes of endoscopic submucosal dissection for early gastric cancer: a single center experience. Surg Endosc. 2013;27:4250–8.PubMedCrossRefPubMedCentralGoogle Scholar
  50. 50.
    Omae M, Fujisaki J, Horiuchi Y, et al. Safety, efficacy, and long-term outcomes for endoscopic submucosal dissection of early esophagogastric junction cancer. Gastric Cancer. 2013;16(2):147–54.PubMedCrossRefPubMedCentralGoogle Scholar
  51. 51.
    Park CH, Kim EH, Kim HY, et al. Clinical outcomes of endoscopic submucosal dissection for early stage esophagogastric junction cancer: a systematic review and meta-analysis. Dig Liver Dis. 2015;47(1):37.PubMedCrossRefPubMedCentralGoogle Scholar
  52. 52.
    Yamada M, Oda I, Nonaka S, et al. Long-term outcome of endoscopic resection of superficial adenocarcinoma of the esophagogastric junction. Endoscopy. 2013;45(12):992–6.PubMedCrossRefPubMedCentralGoogle Scholar
  53. 53.
    Imai K, Kakushima N, Tanaka M, et al. Validation of the application of the Japanese curative criteria for superficial adenocarcinoma at the esophagogastric junction treated by endoscopic submucosal dissection: a long-term analysis. Surg Endosc. 2013;27(7):2436–45.PubMedCrossRefPubMedCentralGoogle Scholar
  54. 54.
    Hirasawa K, Kokawa A, Oka H, et al. Superficial adenocarcinoma of the esophagogastric junction: long-term results of endoscopic submucosal dissection. Gastrointest Endosc. 2010;72(5):960–6.PubMedCrossRefPubMedCentralGoogle Scholar
  55. 55.
    Yoshinaga S, Gotoda T, Kusano C, et al. Clinical impact of endoscopic submucosal dissection for superficial adenocarcinoma located at the esophagogastric junction. Gastrointest Endosc. 2008;67(2):202.PubMedCrossRefPubMedCentralGoogle Scholar
  56. 56.
    Ono, Shunsuke. Ministry of Health, Labour and Welfare (MHLW, Japan). Japanese Scientific Monthly, 2007; p. 60.Google Scholar
  57. 57.
    Jang YS, Lee BE, Kim GH, et al. Factors associated with outcomes in endoscopic submucosal dissection of gastric cardiatumors: a retrospective observational study. Medicine (Baltimore). 2015;94(31):e1201.CrossRefGoogle Scholar
  58. 58.
    Huang Q, Shi J, Xu GF, et al. Risk factors of lymph node metastasis in 1620 early gastric carcinoma radical gastrectomies: a multicenter clinicopathologic study in Jiangsu Province in China. The 2017 Annual Meeting of the Chinese Gastroenterology Society in Xian, China.Google Scholar
  59. 59.
    NCCN Guidelines version 2.2015 Gastric Cancer. http://www.cjcpt.org/files/2015/03-06/2015-NCCN/2015%20NCCN-%E8%83%83%E7%99%8C-V2.pdf. Accessed 19 June 2017.
  60. 60.
    Waddell T, Verheij M, Allum W, et al. Gastric cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;40(suppl 6):1165–76.Google Scholar
  61. 61.
    Association JGC. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 2017;20(1):1–19.CrossRefGoogle Scholar
  62. 62.
    Allum WH, Griffin SM, Watson A, et al. Guidelines for the management of oesophageal and gastric cancer. Gut. 2011;60(11):1449–72.PubMedCrossRefPubMedCentralGoogle Scholar
  63. 63.
    Schlemper RJ, Riddell RH, Kato Y, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut. 2000;47(2):251.PubMedPubMedCentralCrossRefGoogle Scholar
  64. 64.
    You Z, Enqiang L, Zhongsheng L, et al. Preoperative biopsy in gastric mucosal lesions endoscopic submucosal dissection in the value of the value. Chin J Dig Endosc. 2012;29(3):151–4. (in Chinese).Google Scholar
  65. 65.
    Kim YJ, Park JC, Kim JH, et al. Histologic diagnosis based on forceps biopsy is not adequate for determining endoscopic treatment of gastric adenomatous lesions. Endoscopy. 2010;42(08):620–6.PubMedCrossRefPubMedCentralGoogle Scholar
  66. 66.
    Xu G, Zhang W, Lv Y, et al. Risk factors for under-diagnosis of gastric intraepithelial neoplasia and early gastric carcinoma in endoscopic forceps biopsy in comparison with endoscopic submucosal dissection in Chinese patients. Surg Endosc. 2016;30(7):2716–22.PubMedCrossRefPubMedCentralGoogle Scholar
  67. 67.
    Veitch AM, Baglin TP, Gershlick AH, et al. Guidelines for the management of anticoagulant and antiplatelet therapy in patients undergoing endoscopic procedures. Gut. 2008;57(9):1322.PubMedCrossRefPubMedCentralGoogle Scholar
  68. 68.
    Goto O, Fujishiro M, Kodashima S, et al. Feasibility of endoscopic submucosal dissection for patients with chronic renal failure on hemodialysis. Dig Endosc. 2010;22(1):45–8.PubMedCrossRefPubMedCentralGoogle Scholar
  69. 69.
    Myung YS, Hong SJ, Han JP, et al. Effects of administration of a proton pump inhibitor before endoscopic submucosal dissection for differentiated early gastric cancer with ulcer. Gastric Cancer. 2017;20(1):200–6.PubMedCrossRefPubMedCentralGoogle Scholar
  70. 70.
    Fujishiro M, Yahagi N, Kakushima N, et al. Outcomes of endoscopic submucosal dissection for colorectal epithelial neoplasms in 200 consecutive cases. Clin Gastroenterol Hepatol. 2007;5:678–83.PubMedCrossRefPubMedCentralGoogle Scholar
  71. 71.
    Saito Y, Uraoka T, Matsuda T, et al. Endoscopic treatment of large superficial colorectal tumors: a case series of 200 endoscopic submucosal dissections (with video). Gastrointest Endosc. 2007;66:966–73.PubMedCrossRefPubMedCentralGoogle Scholar
  72. 72.
    Yang Z, Wu Q, Liu Z, Wu K, Fan D. Proton pump inhibitors versus histamine-2-receptor antagonists for the management of iatrogenic gastric ulcer after endoscopic mucosal resection or endoscopic submucosal dissection: a meta-analysis of randomized trials. Digestion. 2011;84(4):315–20.PubMedCrossRefPubMedCentralGoogle Scholar
  73. 73.
    Imaeda H, Hosoe N, Suzuki H, et al. Effect of lansoprazole versus roxatidine on prevention of bleeding and promotion of ulcer healing after endoscopic submucosal dissection for superficial gastric neoplasia. J Gastro. 2011;46(11):1267–72.CrossRefGoogle Scholar
  74. 74.
    Goto O, Fujishiro M, Kodashima S, et al. Short-term healing process of artificial ulcers after gastric endoscopic submucosal dissection. Gut Liver. 2011;5(3):293–7.PubMedPubMedCentralCrossRefGoogle Scholar
  75. 75.
    Niimi K, Fujishiro M, Goto O, et al. Prospective single-arm trial of two-week rabeprazole treatment for healing after gastric endoscopic submucosal dissection. Dig Endosc. 2012;24(2):110–6.PubMedCrossRefPubMedCentralGoogle Scholar
  76. 76.
    Kajiura S, Hosokawa A, Ueda A, et al. Effective healing of endoscopic submucosal dissection-induced ulcers by a single week of proton pump inhibitor treatment: a retrospective study. BMC Res Notes. 2015;8:150.PubMedPubMedCentralCrossRefGoogle Scholar
  77. 77.
    Lee SY, Kim JJ, Lee JH, et al. Healing rate of EMR-induced ulcer in relation to the duration of treatment with omeprazole. Gastrointest Endosc. 2004;60(2):213–7.PubMedCrossRefPubMedCentralGoogle Scholar
  78. 78.
    Shin WG, Kim SJ, Choi MH, et al. Can rebamipide and proton pump inhibitor combination therapy promote the healing of endoscopic submucosal dissection-induced ulcers? A randomized, prospective, multicenter study. Gastrointest Endosc. 2012;75(4):739–47.PubMedCrossRefPubMedCentralGoogle Scholar
  79. 79.
    Nakamura M, Tahara T, Shiroeda H, et al. The effect of short-term proton pump inhibitor plus anti-ulcer drug on the healing of endoscopic submucosal dissection-derived artificial ulcer: a randomized controlled trial. Hepato-Gastroenterology. 2015;62(137):219–24.PubMedPubMedCentralGoogle Scholar
  80. 80.
    Itaba S, Iboshi Y, Nakamura K, et al. Low-frequency of bacteremia after endoscopic submucosal dissection of the stomach. Dig Endosc. 2011;23(1):69–72.PubMedCrossRefPubMedCentralGoogle Scholar
  81. 81.
    Chinese Society of Digestive Endoscopy (CSDE). Expert recommendations for perioperative use of endoscopic submucosal dissection for gastric mucosal lesions (2015, Suzhou). Chin J Dig Endosc. 2015;54(10):905–8.Google Scholar
  82. 82.
    Huang Y, Kakushima N, Takizawa K, et al. Risk factors for recurrence of artificial gastric ulcers after endoscopic submucosal dissection. Endoscopy. 2010;43(3):236–9.PubMedCrossRefPubMedCentralGoogle Scholar
  83. 83.
    Fukase K, Kato M, Kikuchi S, et al. Effect of eradication of Helicobacter pylori, on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet. 2008;372(9636):392.PubMedCrossRefPubMedCentralGoogle Scholar
  84. 84.
    Malfertheiner P, Megraud F, O’Morain CA, et al. European Helicobacter and Microbiota Study Group and Consensus panel. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report. Gut. 2017;66(1):6–30.PubMedCrossRefPubMedCentralGoogle Scholar
  85. 85.
    Park YM, Cho E, Kang HY, Kim JM. The effectiveness and safety of endoscopic submucosal dissection compared with endoscopic mucosal resection for early gastric cancer: a systematic review and meta-analysis. Surg Endosc. 2011;25:2666–77.PubMedPubMedCentralCrossRefGoogle Scholar
  86. 86.
    Chung IK, Lee JH, Lee SH, et al. Therapeutic outcomes in 1000 cases of endoscopic submucosal dissection for early gastric neoplasms: Korean ESD Study Group multicenter study. Gastrointest Endosc. 2009;69:1228–35.PubMedCrossRefPubMedCentralGoogle Scholar
  87. 87.
    Koh R, Hirasawa K, Yahara S, et al. Antithrombotic drugs are risk factors for delayed postoperative bleeding after endoscopic submucosal dissection for gastric neoplasms. Gastrointest Endosc. 2013;78:476–83.PubMedCrossRefPubMedCentralGoogle Scholar
  88. 88.
    Lim JH, Kim SG, Kim JW, et al. Do antiplatelets increase the risk of bleeding after endoscopic submucosal dissection of gastric neoplasms? Gastrointest Endosc. 2012;75:719–27.PubMedCrossRefPubMedCentralGoogle Scholar
  89. 89.
    Isomoto H, Shikuwa S, Yamaguchi N, et al. Endoscopic submucosal dissection for early gastric cancer: a large-scale feasibility study. Gut. 2009;58:331–6.PubMedCrossRefPubMedCentralGoogle Scholar
  90. 90.
    Goto O, Fujishiro M, Oda I, et al. A multicenter survey of the management after gastric endoscopic submucosal dissection related to postoperative bleeding. Dig Dis Sci. 2012;57:435–9.PubMedCrossRefPubMedCentralGoogle Scholar
  91. 91.
    Lim SM, Park JC, Lee H, et al. Impact of cumulative time on the clinical outcomes of endoscopic submucosal dissection in gastric neoplasm. Surg Endosc. 2013;27(4):1397–403.PubMedCrossRefPubMedCentralGoogle Scholar
  92. 92.
    Jeon SW, Jung MK, Cho CM, et al. Predictors of immediate bleeding during endoscopic submucosal dissection in gastric lesions. Surg Endosc. 2009;67(9):1974–9.CrossRefGoogle Scholar
  93. 93.
    Jang JS, Choi SR, Graham DY, et al. Risk factors for immediate and delayed bleeding associated with endoscopic submucosal dissection of gastric neoplastic lesions. Scand J Gastroenterol. 2009;44(11):1370–6.PubMedCrossRefPubMedCentralGoogle Scholar
  94. 94.
    Oda I, Gotoda T, Hamanaka H, et al. Endoscopic submucosal dissection for early gastric cancer: technical feasibility, operation time and complications from a large consecutive series. Dig Endosc. 2004;17(1):54–8.CrossRefGoogle Scholar
  95. 95.
    Tsuji Y, Ohata K, Ito T, et al. Risk factors for bleeding after endoscopic submucosal dissection for gastric lesions. Surg Endosc. 2011;16(1):2913–7.Google Scholar
  96. 96.
    Oda I, Suzuki H, Nonaka S, et al. Complications of gastric endoscopic submucosal dissection. Dig Endosc. 2013;25(Suppl S1):71–8.PubMedCrossRefPubMedCentralGoogle Scholar
  97. 97.
    Chan HP, Sang KL. Preventing and controlling bleeding in gastric endoscopic submucosal dissection. Clin Endosc. 2013;46(5):456–62.CrossRefGoogle Scholar
  98. 98.
    Toyokawa T, Inaba T, Omote S, et al. Risk factors for perforation and delayed bleeding associated with endoscopic submucosal dissection for early gastric neoplasms: analysis of 1123 lesions. J Gastro Hepatol. 2012;27(5):907–12.CrossRefGoogle Scholar
  99. 99.
    Ohta T, Ishihara R, Uedo N, et al. Factors predicting perforation during endoscopic submucosal dissection for gastric cancer. Gastrointest Endosc. 2012;75(4):AB136.Google Scholar
  100. 100.
    Solis-Cohen M. Complete endoscopic closure of gastric perforation induced by endoscopic resection of early gastric cancer using endoclips can prevent surgery (with video). Gastrointest Endosc. 2006;63(4):596–601.CrossRefGoogle Scholar
  101. 101.
    Nonaka S, Saito Y, Takisawa H, et al. Safety of carbon dioxide insufflation for upper gastrointestinal tract endoscopic treatment of patients under deep sedation. Surg Endosc. 2010;24(7):1638.PubMedCrossRefPubMedCentralGoogle Scholar
  102. 102.
    Maeda Y, Hirasawa D, Fujita N, et al. A prospective, randomized, double-blind, controlled trial on the efficacy of carbon dioxide insufflation in gastric endoscopic submucosal dissection. Endoscopy. 2013;45(5):335–41.PubMedCrossRefPubMedCentralGoogle Scholar
  103. 103.
    American Society of Gastrointestinal Endoscopy Technology Committee. Endoscopic closure devices. Gastrointest Endosc. 2012;76:244–51.CrossRefGoogle Scholar
  104. 104.
    Tsunada S, Ogata S, Mannen K, et al. Case series of endoscopic balloon dilation to treat a stricture caused by circumferential resection of the gastric antrum by endoscopic submucosal dissection. Gastrointest Endosc. 2008;67(6):979.PubMedCrossRefPubMedCentralGoogle Scholar
  105. 105.
    Lee TH, Hsueh PR, Yeh WC, et al. Low frequency of bacteremia after endoscopic mucosal resection. Gastrointest Endosc. 2000;52(2):223–5.PubMedCrossRefPubMedCentralGoogle Scholar
  106. 106.
    Abe N, Gotoda T, Hirasawa T, et al. Multicenter study of the long-term outcomes of endoscopic submucosal dissection for early gastric cancer in patients 80 years of age or older. Gastric Cancer. 2012;15(1):70–5.PubMedCrossRefPubMedCentralGoogle Scholar
  107. 107.
    Akasaka T, Nishida T, Tsutsui S, et al. Short-term outcomes of endoscopic submucosal dissection (ESD) for early gastric neoplasm: multicenter survey by Osaka University ESD Study Group. Dig Endosc. 2011;23(1):73–7.PubMedCrossRefPubMedCentralGoogle Scholar
  108. 108.
    Hong C, Zheng ZY, Shunying L. Endoscopic submucosal dissection for the treatment of early gastric cancer. Chin J Dig Endosc. 2006;23(5):398–400. (in Chinese)Google Scholar
  109. 109.
    Yoo JH, Shin SJ, Lee KM, et al. How can we predict the presence of missed synchronous lesions after endoscopic submucosal dissection for early gastric cancers or gastric adenomas? J Clin Gastroenterol. 2013;47(2):17–22.CrossRefGoogle Scholar
  110. 110.
    Nasu J, Doi T, Endo H, et al. Characteristics of metachronous multiple early gastric cancers after endoscopic mucosal resection. Gastrointest Endosc. 2006;63(5):990.Google Scholar
  111. 111.
    Yuan L, Enqiang L, Zhiqiang W, et al. Study on the recurrence rate of gastric intraepithelial neoplasia and early carcinoma after endoscopic mucosal resection (EMR). China Contin Med Educ. 2011;03(12):101–3. (in Chinese).Google Scholar
  112. 112.
    Numata N, Oka S, Tanaka S, et al. Risk factors and management of positive horizontal margin in early gastric cancer resected by en bloc endoscopic submucosal dissection. Gastric Cancer. 2015;18(2):332–8.PubMedCrossRefPubMedCentralGoogle Scholar
  113. 113.
    Lee KJ, Kim JH, Kim SI, et al. Clinical significance of colonoscopic examination in patients with early stage of gastric neoplasm undergoing endoscopic submucosal dissection. Scand J Gastro. 2011;46(11):1349–54.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Guifang Xu
    • 1
  • Rui Li
    • 2
  • Dongtao Shi
    • 3
  • Qin Huang
    • 4
    • 5
  • Hiroshi Mashimo
    • 6
  1. 1.Department of GastroenterologyAffiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolNanjingPeople’s Republic of China
  2. 2.Soochow University First Hospital, Soochow UniversitySoochowPeople’s Republic of China
  3. 3.Department of GastroenterologySoochow University First Hospital, Soochow UniversitySoochowPeople’s Republic of China
  4. 4.Pathology and Laboratory MedicineVeterans Affairs Boston Healthcare SystemWest RoxburyUSA
  5. 5.Harvard Medical School and Brigham and Women’s HospitalBostonUSA
  6. 6.VA Boston Healthcare System and Brigham and Women’s Hospital, Harvard Medical SchoolBostonUSA

Personalised recommendations